| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | | Total Revenue | 5,508 | 18,703 | | Cost of Revenue | 2,742 | 2,434 | | | Gross Profit | 2,766 | 16,269 | | | Operating Expenses | | Research Development |
-
|
-
| | Selling General and Administrative | 102 | 95 | | Non Recurring |
-
|
-
| | Others |
-
|
-
| | | | Total Operating Expenses |
-
|
-
| | | | Operating Income or Loss | 2,664 | 16,173 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (93,395) | (649) | | Earnings Before Interest And Taxes | 2,664 | 2,430 | | Interest Expense |
-
|
-
| | Income Before Tax | 2,664 | 2,430 | | Income Tax Expense |
-
|
-
| | Minority Interest |
-
|
-
| | | | Net Income From Continuing Ops | (90,731) | 15,524 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| | Extraordinary Items |
-
|
-
| | Effect Of Accounting Changes |
-
|
-
| | Other Items |
-
|
-
| | | | Net Income | (90,731) | 15,524 | | Preferred Stock And Other Adjustments |
-
|
-
| | | Net Income Applicable To Common Shares | ($90,731) | $15,524 |
|
1.52% Nasdaq 0.00%
Income Statement
